PAMU
KPTI icon

Pictet Asset Management (UK)’s Karyopharm Therapeutics KPTI Stock Holding History

Pictet Asset Management (UK)’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,307
Closed -$680K – 854
2015
Q3 		$680K Hold
4,307
– – ﹤0.01% 810
2015
Q2 		$1.33M Buy
4,307
+160
+4% +$69.2K 0.01% 779
2015
Q1 		$1.69M Buy
4,147
+1,087
+36% +$469K 0.01% 768
2014
Q4 		$1.72M Buy
3,060
+713
+30% +$405K 0.01% 764
2014
Q3 		$1.23M Buy
+2,347
New +$1.32M 0.01% 779

Other funds holding KPTI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet Asset Management (UK)'s KPTI Position: Q4 2015 in Review

Pictet Asset Management (UK) sold out of Karyopharm Therapeutics (KPTI) in Q4 2015, closing a stake of 4,307 shares — an estimated $680K sold.

Pictet Asset Management (UK) first reported a position in KPTI in Q3 2014 and held it in 5 quarters. The position peaked at $1.72M in Q4 2014. 85 funds tracked by Wall St. Rank hold KPTI as of Q4 2015.

  • Pictet Asset Management (UK) reported no remaining Karyopharm Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 4,307 Karyopharm Therapeutics shares in Q4 2015, an estimated $680K.
  • Pictet Asset Management (UK) first reported a position in Karyopharm Therapeutics in Q3 2014 and held it in 5 quarters.
  • Pictet Asset Management (UK)'s Karyopharm Therapeutics position peaked at $1.72M in Q4 2014.
  • 85 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q4 2015.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2015, filed 12 Feb 2016.